Lymph Node Structure and Function in Tolerance: Role of Laminins

耐受性中的淋巴结结构和功能:层粘连蛋白的作用

基本信息

  • 批准号:
    9056643
  • 负责人:
  • 金额:
    $ 38.38万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-04-20 至 2020-03-31
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): Achieving tolerance remains the most important goal in transplantation immunology. Models of tolerance employing co-stimulatory blockade are among the most robust and clinically relevant approaches. Much is known about the mechanisms of tolerance that are operative during co-stimulatory blockade, such as energy, apoptosis, and regulatory T cells (Treg). However, it is often difficult to induce and maintain robust tolerance that is resistant to external perturbations. This suggests that other important immunologic mechanisms that determine tolerance remain to be elucidated. Our laboratory has focused on the role of migration, trafficking and secondary lymphoid organ structure as crucial regulatory processes that determine whether immune interactions result in immunity versus tolerance. In several key publications we demonstrated that tolerance is initiated in lymph nodes (LN) through the precise interaction of specific alloantigen presenting cells with naïve antigen specific T cells to generate regulatory suppressive T cells. This interaction occurs in the LN, and is dependent on the intricate coordination of many molecular signals. Subsequent trafficking of the suppressive T cells is critical, so that migration from blood to grafts and then into lymphatic has distinct and unique suppressive effects, in comparison to migration through blood and LNs. We have elucidated several novel and unexpected mechanisms that are required for tolerance induction, and these mechanisms relate to the interaction of LN structure with the cellular and molecular mechanisms of lymphocyte responses. The results demonstrate that T cells destined to become suppressors are found in only one region of the LN, called the cortical ridge. In contrast, T cells destined to become effectors are found scattered throughout the LN. The cortical ridge is particularly rich in specialized fibers and stromal cells, called fibroblastic reicular cells (FRC), suggesting a unique function or arrangement for these cells and their associated fibers. Together these observations lead to the hypothesis that the LN domain of the cortical ridge, that encompasses the HEV and their surrounding stromal fibers, is a major locus for tolerization. During tolerization naïve T cells and alloantigen presenting pDC enter this domain and remain around the HEV within the stromal fibers. Precise stromal cell function and fiber arrangement are required to create and maintain the microenvironment necessary for Treg induction. These Treg persist in this high-traffic region and act as gatekeepers for new T cells that traverse the HEV. These Treg regulate the migration, activation, and fate of new naïve antigen specific T cells as they enter the LN, and thus the Treg determine tolerance or immunity.
 描述(由应用程序提供):实现耐受性仍然是移植免疫学中最重要的目标。采用共刺激性阻滞的容忍模型是最强大和临床相关的方法之一。关于在共刺激性阻滞中运行的耐受性机制,例如能量,凋亡和调节性T细胞(TREG)。但是,通常很难诱导和保持对外部扰动具有抗性的耐受性。这表明确定公差的其他重要免疫机制尚待阐明。我们的实验室专注于移民,贩运和次级淋巴器官结构的作用,这是确定免疫相互作用是否导致免疫学和耐受性的关键调节过程。在几个关键出版物中,我们证明了通过特定的同种抗原细胞与幼稚的抗原特异性T细胞的精确相互作用在淋巴结(LN)中启动耐受性,以产生调节性抑制性T细胞。这种相互作用发生在LN,并且 取决于许多分子信号的复杂协调。随后对抑制性T细胞的运输至关重要,因此与通过血液和LN的迁移相比,从血液到移植物再迁移到淋巴管中具有独特而独特的抑制作用。我们阐明了耐受性诱导所需的几种新颖和意外的机制,以及与LN结构与淋巴细胞反应的细胞和分子机制相互作用有关的这些机制。结果表明,只有在LN的一个区域,称为皮质脊的T细胞。相比之下,发现注定要成为生效子的T细胞散布在整个LN中。皮质脊特别富含专门的纤维和基质细胞,称为成纤维细胞胶状细胞(FRC),这表明这些细胞及其相关纤维具有独特的功能或排列。这些观察结果一起导致了一个假设,即皮质脊的LN结构域增强了HEV及其周围的基质纤维,是耐受性的主要基因座。在耐受性的过程中,幼稚的T细胞和同种抗原呈现PDC进入该结构域,并在基质纤维中留在HEV周围。需要精确的基质细胞功能和纤维排列来创建和维持Treg诱导所需的微环境。这些Treg持续存在在这个高流量区域,并充当横穿HEV的新T细胞的守门人。这些Treg调节了新的幼稚抗原特异性T细胞进入LN时的迁移,激活和命运,因此Treg确定了公差或免疫力。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jonathan S Bromberg其他文献

Jonathan S Bromberg的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jonathan S Bromberg', 18)}}的其他基金

Mechanisms of microbiome-driven cardiac allograft outcomes
微生物组驱动的同种异体心脏移植结果的机制
  • 批准号:
    10477625
  • 财政年份:
    2022
  • 资助金额:
    $ 38.38万
  • 项目类别:
Mechanisms of microbiome-driven cardiac allograft outcomes
微生物组驱动的同种异体心脏移植结果的机制
  • 批准号:
    10621899
  • 财政年份:
    2022
  • 资助金额:
    $ 38.38万
  • 项目类别:
Reshaping lymph node stroma for transplant tolerance
重塑淋巴结基质以提高移植耐受性
  • 批准号:
    10662321
  • 财政年份:
    2020
  • 资助金额:
    $ 38.38万
  • 项目类别:
Reshaping lymph node stroma for transplant tolerance
重塑淋巴结基质以提高移植耐受性
  • 批准号:
    10224026
  • 财政年份:
    2020
  • 资助金额:
    $ 38.38万
  • 项目类别:
Reshaping lymph node stroma for transplant tolerance
重塑淋巴结基质以提高移植耐受性
  • 批准号:
    10024598
  • 财政年份:
    2020
  • 资助金额:
    $ 38.38万
  • 项目类别:
Reshaping lymph node stroma for transplant tolerance
重塑淋巴结基质以提高移植耐受性
  • 批准号:
    10431927
  • 财政年份:
    2020
  • 资助金额:
    $ 38.38万
  • 项目类别:
Immunological and functional consequences triggered by the gut microbiota regulate alloimmunity and cardiac transplant outcome
肠道微生物群引发的免疫和功能后果调节同种免疫和心脏移植结果
  • 批准号:
    10439697
  • 财政年份:
    2019
  • 资助金额:
    $ 38.38万
  • 项目类别:
Immunological and functional consequences triggered by the gut microbiota regulate alloimmunity and cardiac transplant outcome
肠道微生物群引发的免疫和功能后果调节同种免疫和心脏移植结果
  • 批准号:
    10202721
  • 财政年份:
    2019
  • 资助金额:
    $ 38.38万
  • 项目类别:
Immunological and functional consequences triggered by the gut microbiota regulate alloimmunity and cardiac transplant outcome
肠道微生物群引发的免疫和功能后果调节同种免疫和心脏移植结果
  • 批准号:
    9975884
  • 财政年份:
    2019
  • 资助金额:
    $ 38.38万
  • 项目类别:
Immunological and functional consequences triggered by the gut microbiota regulate alloimmunity and cardiac transplant outcome
肠道微生物群引发的免疫和功能后果调节同种免疫和心脏移植结果
  • 批准号:
    9795098
  • 财政年份:
    2019
  • 资助金额:
    $ 38.38万
  • 项目类别:

相似国自然基金

B7H4-LILRB4信号调控B细胞代谢重编程机制在同种抗体产生及防治AMR中的作用
  • 批准号:
    82371792
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目
BRD4调控B细胞功能的机制及其在抗体介导的排斥反应中的作用研究
  • 批准号:
    81871262
  • 批准年份:
    2018
  • 资助金额:
    57.0 万元
  • 项目类别:
    面上项目
去糖基化CD36单抗用于预防CD36抗体引起的FNAIT免疫治疗研究
  • 批准号:
    81601451
  • 批准年份:
    2016
  • 资助金额:
    17.5 万元
  • 项目类别:
    青年科学基金项目
同源干细胞移植体液免疫记忆细胞重建预防肾移植抗体介导排斥反应的机制研究
  • 批准号:
    81500574
  • 批准年份:
    2015
  • 资助金额:
    17.0 万元
  • 项目类别:
    青年科学基金项目
抗体药物偶联物(ADC)靶向清除CD103表达细胞对小鼠同种胰岛移植抗排斥反应的作用及其机制的研究
  • 批准号:
    81571553
  • 批准年份:
    2015
  • 资助金额:
    25.0 万元
  • 项目类别:
    面上项目

相似海外基金

Innate Immune Receptors that Promote RBC Alloimmunization
促进红细胞同种免疫的先天免疫受体
  • 批准号:
    10192794
  • 财政年份:
    2017
  • 资助金额:
    $ 38.38万
  • 项目类别:
Lymph Node Structure and Function in Tolerance: Role of Laminins
耐受性中的淋巴结结构和功能:层粘连蛋白的作用
  • 批准号:
    9250668
  • 财政年份:
    2015
  • 资助金额:
    $ 38.38万
  • 项目类别:
Mechanistic basis of allogeneic IgG-induced tumor eradication
同种异体IgG诱导肿瘤根除的机制基础
  • 批准号:
    9089595
  • 财政年份:
    2015
  • 资助金额:
    $ 38.38万
  • 项目类别:
Mechanistic basis of allogeneic IgG-induced tumor eradication
同种异体IgG诱导肿瘤根除的机制基础
  • 批准号:
    8907654
  • 财政年份:
    2015
  • 资助金额:
    $ 38.38万
  • 项目类别:
Lymph Node Structure and Function in Tolerance: Role of Laminins
耐受性中的淋巴结结构和功能:层粘连蛋白的作用
  • 批准号:
    8960981
  • 财政年份:
    2015
  • 资助金额:
    $ 38.38万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了